Breast Cancer
Bridging the Gap: Metastatic Breast Cancer
"Dr. Hahn's beside manner is what helps me stay as positive as I am."
Breast Cancer Topics
Latest
Just the Facts About Breast Cancer Chemo Regime AC + T
How AC + T works, how to prep for treatment, and then what to expect once you have it (including side effects).
What Should You Know About Taxol/Taxotere and Cytoxan (TC) Therapy?
Taxol/Taxotere and Cytoxan (TC) therapy is one of the most common types of chemotherapy given to women with early-stage breast cancer. Here’s duration information and possible side effects, including chemo brain and fatigue.
Which Should You Have -- Lumpectomy or a Mastectomy?
"Take the time to look deep into yourself for the treatment option that feels right. If you need help, ask your doctor if there's a service at the hospital that deals with medical decision-making; and if there is, use it."
Obesity Lowers Breast Cancer Risk in Young Women
Young women with high body fat levels are less likely to develop breast cancer before menopause, suggests a study conducted by an international team of researchers led by the National Institutes of Health (NIH).
10 Facts About BRCA Gene Mutations
Hereditary breast and ovarian cancer have been associated with mutations in two genes, BRCA1 and BRCA2. Here’s what you should know.
Meet the Experts
PJ Hamel
Patient Expert
Bethany Kandel
Health WriterBethany Kandel is a New York-based journalist, health writer, and author. She is also a breast cancer survivor.
Phyllis Johnson
Patient ExpertHealth News
Higher Vitamin D Levels Linked to Lower Breast Cancer Risk
Results of a recent study suggest low blood levels of vitamin D are associated with an increased risk for breast cancer in women over the age of 55.
Potential New Treatment for Aggressive Breast Cancer Identified
Researchers from the Mayo Clinic in Rochester, Minnesota, discovered that an FDA-approved treatment for certain cancers of the blood may significantly reduce the growth of triple-negative breast cancers.
FDA Okays Genetic Home Test for Cancer
This week, the U.S. Food and Drug Administration (FDA) authorized 23andMe to market the first direct-to-consumer test for three specific genetic mutations known to increase the risk for breast, ovarian, and prostate cancer. Called the Personal Genome ...